Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema

Chinese Medical Journal

Volumn 125, Issue 17, 2012, Pages 3015-3021

  Zhao, Ying ^a,b,c   Cui, Ai ^a,b,c   Wang, Feng ^a,b,c   Wang, Xiao juan ^a,b,c   Chen, Xing ^a   Jin, Mu lan ^a   Huang Dr , Ke wu ^a,b,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Institute of Respiratory Medicine   (China)

^c Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders   (China)

Author keywords

Airway inflammation; Emphysema; Exhaled nitric oxide; Pulmonary fibrosis

Indexed keywords

CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SALBUTAMOL;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; CONTROLLED STUDY; EMPHYSEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MALE; PNEUMONIA; SPUTUM ANALYSIS;

AGED; BREATH TESTS; CHEMOKINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PNEUMONIA; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; SPUTUM;

EID: 84866111123     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.17.009     Document Type: Article

References (25)

1. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-593.
2. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990; 84: 365-369.
3. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006; 130: 1541-1546.
4. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721.
5. George SC, Hogman M, Permutt S, Silkoff PE. Modeling pulmonary nitric oxide exchange. J Appl Physiol 2004; 96: 831-839.
6. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998; 85: 653-666.
7. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 2007; 131: 1353-1362.
8. Paraskakis E, Brindicci C, Fleming L, Krol R, Kharitonov SA, Wilson NM, et al. Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med 2006; 174: 260-267.
9. Gelb AF, Flynn Taylor C, Krishnan A, Fraser C, Shinar CM, Schein MJ, et al. Central and peripheral airway sites of nitric oxide gas exchange in COPD. Chest 2010; 137: 575-584.
10. Lehtimäki L, Kankaanranta H, Saarelainen S, Hahtola P, Järvenpää R, Koivula T, et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001; 163: 1557-1561.
11. Saleh D, Barnes PJ, Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: 1763-1769.
12. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, et al. An immune basis for lung parenchmal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004; 1: e8.
13. Pignatti P, Brunetti G, Moretto D, Yacoub MR, Fiori M, Balbi B, et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am J Respir Crit Care Med 2006; 173: 310-317.
14. Burdick MD, Murray LA, Keane MP, Xue YY, Zisman DA, Belperio JA, et al. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am J Respir Crit Care Med 2005; 171: 261-268.
15. Mejia M, Carrillo G, Rojas-Serrano J, Estrada A, Suárez T, Alonso D, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10-15.
16. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
17. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
18. Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol 2007; 102: 417-425.
19. Kerckx Y, Michils A, Van Muylem A. Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients. J Appl Physiol 2008; 104: 918-924.
20. Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 2006; 61: 744-746.
21. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
22. Pizzichini MM, Popov TA, Efthimiadis A, Hussack P, Evans S, Pizzichini E, et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 866-869.
23. Van Straaten JF, Postma DS, Coers W, Noordhoek JA, Kauffman HF, Timens W. Macrophages in lung tissue from patients with pulmonary emphysema express both inducible and endothelial nitric oxide synthase. Mod Pathol 1998; 11: 648-655.
24. Antoniou KM, Alexandrakis M, Tzanakis N, Tsiligianni I, Tzortzaki EG, Siafakas NM, et al. Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis. Respiration 2005; 72: 32-38.
25. Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999; 104: 1041-1050.